Certificate

The Balancing Act of Glaucoma

A Try Not To Blink CE/CME Podcast

Please complete the following posttest and evaluation in order to receive your certificate.

Jointly Provided by the Institute for Continuing Healthcare Education (Institute) and American Academy of CME (Academy).

Full Name*

First NameLast Name

E-mail*

Confirmation Emailexample@example.com

The certificate emails auto-generated by this form are blocked by comcast.net email addresses. Please use an alternate email address if possible, or contact cpagano@cmematters.org after submitting your form.

Profession*

School(s): Students: please select the school(s) you are attending. Preceptors: please select the school(s) from where you are receiving students (use the ctrl button to chose multiple schools)

Date*

Date

1. What patient factors help gauge treatment and target goal pressures?*

The correct answer is all of the above.

2. What is the only modifiable risk factor for glaucoma?*

AgeGeneticsCorneal thicknessIntraocular pressure

The correct answer is intraocular pressure.

3. Based on the Rotterdam Eye study, having a primary family relative with glaucoma increases your risk by up to …*

2x4x9x20x

The correct answer is 9x.

4. Is central corneal thickness (CCT) an independent risk factor for glaucoma?*

No. The cornea doesn’t relate to glaucoma.Not directly, but you must factor that in while checking eye pressure.Yes. Low CCT effects the accuracy of checking pressure and its relation to ocular hysteresis.Yes. Patients with high CCT are 50% likely to have glaucoma.

The correct answer is yes, low CCT effects the accuracy of checking pressure and its relation to ocular hysteresis.

5. Which of the following is not a main target mechanism for treating glaucoma?*

Increased uveoscleral outflowIncreased trabecular meshwork outflowIncrease corneal epithelial penetrationDecreased aqueous production

The correct answer is increase corneal epithelial penetration.

6. A prostaglandin analogue should lead to an approximate reduction in intraocular pressure by approximately what percent?*

10%20%30%50%

The correct answer is 30%.

7. What testing is most likely to show changes first in progressive glaucoma?*

Visual acuityVisual field testingOCT analysis of the optic nerve headExtraocular muscle evaluation

The correct answer is OCT analysis of the optic nerve head.

8. What is the only FDA approved intraocular drug eluting glaucoma treatment?*

Travaprost sustained releasedBimatoprost sustained releaseDexamethasone implantRanibizumab injection

The correct answer is bimatoprost sustained release.

9. What is an example of a structural assessment of a patient’s glaucoma?*

OCT retinal nerve fiber layer thicknessVisual Field TestVisual AcuityColor vision testing

The correct answer is OCT retinal nerve fiber layer thickness.

10. What is an example of a functional assessment of a patient’s glaucoma?*

Electrophysiological testingOCT Ganglion cell complex thicknessOptic nerve photographyNerve fiber dropout with red free filter photo

The correct answer is electrophysiological testing.

	5	4	3	2	1
The content covered was useful and relevant to my practice or education.
The activity was fair, balanced, and free of bias.
The activity improved my knowledge of this clinical issue.
I am better able to describe the specific process by which glaucoma occurs.
I am better able to list the currently available instruments useful in identifying and monitoring glaucoma and glaucoma progression.
I am better able to identify the current and emerging treatment options for glaucoma.
I am better able to list the risk factors for glaucoma.

POST-TEST

EVALUATION